ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,813.12
-0.66%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. TherapeuticsMD Inc (TXMD) Share Price

TXMD TherapeuticsMD Inc

2.14
0.03 (1.42%)
25 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 TherapeuticsMD Inc NASDAQ:TXMD NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.03 1.42 2.14 2.00 5.00 2.14 2.08 2.08 8,092 04:00:05   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 1.3M -10.28M -0.9719 -2.20 22.63M
 Type  Size  Price  Time  Units 
 9 2 2.05 21:44:55 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore TXMD News
10/05/202421:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/05/202421:15EDGAR2Form 8-K - Current report
10/05/202421:05BWTherapeuticsMD Announces First Quarter 2024 Financial Results
29/03/202420:00BWTherapeuticsMD Announces Full Year 2023 Financial Results
07/12/202321:51EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
06/12/202316:36EDGAR2Form 144 - Report of proposed sale of securities
17/11/202314:28EDGAR2Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Period
Draw mode
Data Downloads for TXMD

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest TherapeuticsMD Inc Articles